Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:2.7.7.48 (transcriptase)
 9,479 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The complete nucleotide sequence of the Japanese encephalitis virus (JEV) genome RNA was determined. The JEV genome contains 10,976 nucleotides and encodes a single long open reading frame (ORF) of 10,296 nucleotides corresponding to 3432 amino acid residues. This long polypeptide is thought to be cleaved into three structural proteins and several nonstructural proteins of the virus. The genetic location of the three structural proteins was determined by comparing the deduced amino acid sequence from the nucleotide sequence with the N-terminal amino acid sequences that were determined from the three purified structural proteins. The C-terminal region of the ORF may encode a RNA-dependent RNA polymerase which has significant sequence homology with those of other RNA viruses.
Virology 1987 Dec
PMID:Complete nucleotide sequence of the Japanese encephalitis virus genome RNA. 368 27

Oligodeoxynucleotides covalently linked to an acridine derivative were targeted to part of the 3'-terminal sequence which is common to the eight RNAs of type A influenza viruses. The cytopathic effect of the virus on MDCK cells in culture was strongly decreased by a heptanucleotide covalently attached to the acridine ring. Control experiments using other oligonucleotide sequences showed that the effect was specific for the complementary sequence of the 3'-terminal region of the viral RNAs. The RNA transcriptase reaction of a type A virus was also selectively inhibited in vitro by the heptanucleotide-acridine conjugate. A type B influenza virus was used as a control. The common sequence at the 3' end of its eight viral RNAs is different from that of type A viruses. Three mismatches were expected with the heptanucleotide which was fully complementary to type A viral RNAs. This heptanucleotide had no effect on the cytopathic effect of a type B influenza virus. These results demonstrate that viral RNAs are specific targets for the oligonucleotide-acridine conjugate that inhibits the cytopathic effect of type A influenza viruses.
Nucleic Acids Res 1987 Dec 10
PMID:Selective inhibition of the cytopathic effect of type A influenza viruses by oligodeoxynucleotides covalently linked to an intercalating agent. 369 85

RNA polymerase activities in parental strains of influenza A and B viruses nonpathogenic for mice and their pathogenic variants have been studied. The parental strains are A/seal/Massachusetts 1/80, A/USSR 05/81, A/Philippines 2/82, B/Singapore 222/79. The RNA polymerase activity has been also studied in recombinant strains obtained by crossing various parental strains, one of which is pathogenic for mice (AR/PR 8/34), and having different degrees of pathogenicity. The nonpathogenic viruses had low transcriptase activity. RNA polymerase activity in pathogenic variants is shown to be 1.5-3 times higher than that in the parental strains. All the recombinants, whatever their pathogenicity, had approximately the same transcriptase activities which were 1.5-2 times higher than those registered in parental nonpathogenic strains.
Mol Gen Mikrobiol Virusol 1986 Dec
PMID:[Activity of virion RNA-polymerase in influenza A and B virus variants with different pathogenicities for mice]. 380 28

Two human strains (AD-169 and C87) and one simian strain (GR2757) of cytomegalovirus (CMV) have been purified from the extracellular fluids of virus-infected cultures by sedimentation through a sucrose gradient followed by brief centrifugation in a preformed gradient of CsCl. Enveloped virus particles were located in the density region, 1.219 g/cm(3), and nucleocapsids at 1.263 g/cm(3). Purified viral DNA, both human and simian, sedimented in the region of 55S in neutral sucrose gradients with herpes simplex type I DNA as a marker; the molecular weight of the CMV DNA was estimated as approximately 10(8). The density of the viral DNA determined by analytical ultracentrifugation was 1.716 g/cm(3) for the human strains and 1.710 g/cm(3) for the simian strain. Tritiated viral complementary RNA synthesized in vitro with Escherichia coli transcriptase has been used for detection and localization of viral genome in membrane hybridization and in situ cytohybridization. Newly synthesized viral DNA appeared 24 h after infection and localized at two acrocentric areas; later the viral DNA distributed in a band resembling intranuclear inclusions 48 to 70 h after infection. Total DNA synthesis began to increase 24 h after infection and reached its peak at 70 h; RNA synthesis increased at 13 h, and reached its peak at 24 to 33 h. The viral DNA was also labeled with (3)H-TTP by repair-synthesis in vitro with Kornberg's enzyme in order to analyze the purity of the DNA and for detection of viral DNA by DNA-DNA reassociation kinetics.
J Virol 1973 Dec
PMID:Human cytomegalovirus. I. Purification and characterization of viral DNA. 412 79

O-methylthreonine (OMT), an isosteric analogue of isoleucine, markedly inhibited growth of Escherichia coli 15. This inhibition was overcome most effectively by addition of isoleucine, valine, or leucine to the medium and less effectively by addition of threonine. The dipeptide, valylleucine, also relieved the OMT-induced inhibition but only after a lag period, suggesting that valine and leucine, liberated by dipeptidase action, compete with OMT for entry into the cell. OMT was activated and transferred to transfer ribonucleic acid (RNA) by isoleucyl-RNA synthetase in vitro. The rate of OMT incorporation into protein of intact cells was comparable to that of isoleucine. In contrast to isoleucine, very high concentrations of OMT were required to inhibit threonine deaminase, and the inhibition was strictly competitive with threonine. In addition, OMT inhibited a threonine deaminase preparation desensitized to isoleucine inhibition.
J Bacteriol 1967 Dec
PMID:O-methylthreonine inhibition of growth and of threonine deaminase in Escherichia coli. 429 94

The endogenous transcriptase present in purified vesicular stomatitis (VS) virions was solubilized with a Triton X-100 high-salt solution. The polymerase activity was purified on glycerol gradients and by phosphocellulose column chromatography; the viral proteins present in the active enzyme fractions were identified by sodium dodecyl sulfate polyacrylamide gel electrophoresis. It was demonstrated that L protein, but not NS protein, was required for in vitro RNA synthesis on the VS viral nucleocapsid template. Solubilized L protein rebinds to the ribonucleoprotein template when the transcription complex is reconstituted, and the RNA synthesized in vitro by purified L protein hybridizes to virion RNA. Cyanogen bromide peptide fingerprints indicate that the large L protein is a unique polypeptide chain. It is concluded that the L protein functions as the transcriptase, and the nucleocapsid NS protein is not essential for in vitro RNA synthesis.
J Virol 1973 Dec
PMID:L protein requirement for in vitro RNA synthesis by vesicular stomatitis virus. 435 10

A cytoplasmic, microsomal bound RNA-dependent RNA polymerase has been purified 2500-fold from rabbit reticulocyte lysates. The synthesis of RNA with the purified enzyme is absolutely dependent on the addition of an RNA template. The best template is hemoglobin messenger RNA, while bacteriophage RNA and poly(A,G) are less active, and DNA is completely inactive as a template. With poly(A,G) as a template, only UTP and CTP are incorporated into polynucleotide chains, indicating that the RNA polymerase is an RNA replicase and not a terminal transferase. With messenger RNA as a template, all four ribonucleoside triphosphates are required for maximal activity. The RNA-dependent RNA polymerase reaction is extremely sensitive to low concentrations of heme, rifamycin AF/013, and ribonuclease and resistant to actinomycin D and DNase. The discovery of RNA-directed RNA synthesis in reticulocytes offers an additional site for control of gene expression in mammalian cells and provides a possible mechanism for amplification of the expression of specific genes.
Proc Natl Acad Sci U S A 1973 Dec
PMID:Reticulocyte RNA-dependent RNA polymerase. 451 33

Infection by ribonucleic acid (RNA) bacteriophage R23 inhibited the synthesis of beta-galactosidase in Escherichia coli. The inhibition, although not complete, was apparent shortly after infection and was maximal after the first 20 min of infection. R23 diminished the beta-galactosidase-synthesizing capacity when inducer was added after phage infection, but not when infection followed inducer removal. These findings suggested that the primary effect of R23 on enzyme-forming capacity was limitation of synthesis of enzyme-specific messenger RNA. Studies with ultraviolet irradiated phage and amber mutants of R23 indicated that the inhibitory process could be separated into two phases. Early inhibition did not require the expression of the viral genome, whereas late inhibition required the expression of the viral RNA synthetase cistron.
J Virol 1968 Dec
PMID:Effect of infection with ribonucleic acid bacteriophage R23 on the inducible synthesis of beta-galactosidase in Escherichia coli. 491 Aug 18

Jaagsiekte (ovine pulmonary adenomatosis) was transmitted to new-born lambs by inoculation of the microsomal fraction of a cytoplasmic extract of cultured tumour cells or tumour tissue. Various treatments of the biologically active fraction were carried out to differentiate between various classes of possible aetiological agents. The results obtained suggested the involvement of a membrane-associated RNA containing virus. Reverse transcriptase activity dependent on Mg++ was subsequently demonstrated in these extracts and in lung exudate, and was shown to be associated with particles banding at a density 1,175 in sucrose gradients. These characteristics, as well as the appearance of the particles in the electron microscope, are similar to those reported for Type B and Type D retroviruses. Serial transmissions of jaagsiekte over a number of years, using cytoplasmic extracts and purified virus, strongly suggest that this virus is the aetiologic agent of jaagsiekte.
Onderstepoort J Vet Res 1980 Dec
PMID:Aetiology of jaagsiekte: transmission by means of subcellular fractions and evidence for the involvement of a retrovirus. 616 73

Macbecin I showed marked antitumor activity against intraperitoneally (ip) inoculated leukemia P388, melanoma B16, and Ehrlich carcinoma in mice on ip administration. The maximum effect measured in terms of ILS% (increase of life span) was 97 at a daily dose level of 10 mg/kg for leukemia P388, 103 at 5 mg/kg for melanoma B16, and 206 at 10 mg/kg for Ehrlich carcinoma. The effect of macbecin I on leukemia L1210 was slight (39 ILS%) and no activity was observed against leukemia L5178Y or P388/P-3 (a line of P388 resistant to ansamitocin P-3), or MOPC-104E myloma. Three to six hours after administration of 0.5 mg/kg or more of macbecin I to mice bearing ascites leukemia P388 cells, typical karyorrhexis followed by cytolysis in P388 cells was observed. Cytocidal changes induced by macbecin I were also observed in cells which were temporarily prevented from entering mitosis by treatment with known antitumor agents such as 5-fluorouracil, cyclophosphamide, and neocarzinostatin, whereas such cytolysis was not observed in cells which were arrested in metaphase by treatment with ansamitocin P-3. Cytotoxicity of macbecin I to cultured KB cells was observed at doses of 10(-1) micrograms/ml and more. Reverse transcriptase and terminal deoxynucleotidyl transferase activities were not inhibited by macbecin I.
Gan 1982 Dec
PMID:Antitumor and cytocidal activities of a newly isolated benzenoid ansamycin, macbecin I. 618 64


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>